Literature DB >> 24120077

That chorioamnionitis is a risk factor for bronchopulmonary dysplasia--the case against.

Thierry Lacaze-Masmonteil1.   

Abstract

Bronchopulmonary dysplasia (BPD) is the most frequent long term sequelae in infants born at less than 29 weeks of gestational age (GA) and histological chorioamnionitis (CA) is the most frequent condition associated with very preterm birth. Numerous studies have explored the association between BPD and CA with conflicting results. This inconsistency may be attributable to differences in populations, definitions, methods, and whether potential confounding factors such as GA, antenatal steroids, and post natal events were considered. A recent systematic review and meta-analysis shows some evidence of an association between BPD and CA; however, results adjusting for important confounders show more conservative measures of association. In addition, there was evidence of publication bias: when controlling for publication bias the results were more conservative and adjusted results were no longer significant. Recent large cohort studies not included in the systematic review do not support the belief that CA is associated with an increased risk of BPD. Despite a large body of evidence, CA cannot be definitively considered a risk factor for BPD.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Chorioamnionitis; Neonate; Preterm infant

Mesh:

Year:  2013        PMID: 24120077     DOI: 10.1016/j.prrv.2013.09.005

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  16 in total

1.  Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort.

Authors:  A R Ballard; L H Mallett; J E Pruszynski; J B Cantey
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

2.  Is bronchopulmonary dysplasia decided before birth?

Authors:  Vineet Bhandari; Abhay Lodha
Journal:  Pediatr Res       Date:  2020-02-17       Impact factor: 3.756

Review 3.  Can maternal DHA supplementation offer long-term protection against neonatal hyperoxic lung injury?

Authors:  Krithika Lingappan; Bhagavatula Moorthy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-11       Impact factor: 5.464

Review 4.  Animal models of bronchopulmonary dysplasia. The term mouse models.

Authors:  Jessica Berger; Vineet Bhandari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-10       Impact factor: 5.464

Review 5.  Potential contribution of type I alveolar epithelial cells to chronic neonatal lung disease.

Authors:  Henry J Rozycki
Journal:  Front Pediatr       Date:  2014-05-19       Impact factor: 3.418

6.  Chorioamnionitis appears not to be a Risk Factor for Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis.

Authors:  Elham Behbodi; Eduardo Villamor-Martínez; Pieter L J Degraeuwe; Eduardo Villamor
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

Review 7.  Probiotic Supplementation in Preterm Infants Does Not Affect the Risk of Bronchopulmonary Dysplasia: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Eduardo Villamor-Martínez; Maria Pierro; Giacomo Cavallaro; Fabio Mosca; Boris Kramer; Eduardo Villamor
Journal:  Nutrients       Date:  2017-10-31       Impact factor: 5.717

8.  Characterization of the innate immune response in a novel murine model mimicking bronchopulmonary dysplasia.

Authors:  Chanèle Cyr-Depauw; Maria Hurskainen; Arul Vadivel; Ivana Mižíková; Flore Lesage; Bernard Thébaud
Journal:  Pediatr Res       Date:  2020-05-20       Impact factor: 3.756

Review 9.  Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.

Authors:  Gloria S Pryhuber
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

10.  Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study.

Authors:  H Nakanishi; A Uchiyama; S Kusuda
Journal:  J Perinatol       Date:  2016-07-21       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.